Participations à des congrès et colloques internationaux (62)

  1. 48. Andriantafika, M., Willermain, F., Makhoul, D., Verougstreate, C., & Caspers, L. (2004). Uveites secondaires à une hypersensibilité tuberculinique: Etude prospective des caractéristiques cliniques et de l’effet d’un traitement antituberculeux adjuvant. Paper session presented at OB 2004 (November 2004).
  2. 49. Willermain, F., Cabay, L., Dulku, S., Blero, D., Driessen, C., De Graef, C., Miot, F., Suarez, X., Duhant, T., Velu, T., Caspers, L., & Bruyns, C. (2002). PPAR gamma agonist 15 J2 modulates inflammatory response in Human Retial pigment epithelial cells. Paper session presented at ARVO (May 2003: Fort Lauderdale, Fl, USA).
  3. 50. Cabay, L., Willermain, F., Lespagnard, L., Nowak, B., Dargent, J.-L., Maho, A., Baffi, J., Witta, Y., Velu, T., Libert, J., Caspers, L., & Bruyns, C. (2001). CXCR4 expressin on vitreoretinal membranes from macular pucker and proliferative vitreo-retinopathy. Paper session presented at ARVO Meeting (May 2002: Fort Lauderdale, Florida, USA).
  4. 51. Willermain, F., Caspers, L., Nowak, B., Stordeur, P., Mosselmans, R., Salmon, I., Velu, T., & Bruyns, C. (2001). Retinal pigment epithelial cells phagocyte Tcell lymphocytes: Possible implication for the immune privilege of the eye. Paper session presented at ARVO (5/2001: Fort Lauderdale Fl USA).
  5. 52. Willermain, F., Skolik, S., Bafi, J., Velu, T., Caspers, L., & Csacy, C. (2000). Vascular endothelial growth factor (VEGF 165) overexpression in the subretinal space might initiate RPE graft rejection. Paper session presented at Symposium de la Société d’Ophtalmo-Immunoinfectiologie Francophone. (17-18 Mars 2000: Paris - France).
  6. 53. Skolik, S., Willermain, F., Caspers, L., Velu, T., & Csaky, K. (2000). RPE cell transplantation in the subretinal space compromized by gene transfer-mediated VEGF production. Paper session presented at Fifth International Symposium on uveitis (March 26-29, 2000: Buenos Aires).
  7. 54. Willermain, F., Skolik, S., Bafi, J., Velu, T., Caspers, L., & Csacy, C. (2000). Vascular endothelial growth factor (VEGF 165) overexpression in the subretinal pigment epithelium transplantation in the rat: Possible alteration of the immune privilege. Paper session presented at ARVO (5.2000: Fort Lauderdale. Florida USA).
  8. 55. Willermain, F., Caspers, L., Dubois, C., Salmon, I., Velu, T., & Bruyns, C. (2000). RPE Inhibition of T cell roliferation: Role of Apoptosis and Phagocytosis. Paper session presented at Ever (10/2000: Palma de Mallorca).
  9. 56. Bali, E., Willermain, F., Bruyns, C., Dubois, C., Velu, T., Dehou, M.-F., Libert, J., & Caspers, L. (2000). Interleukin-10 gene transfer in an experimental model of PVR. Paper session presented at Ever (10/2000: Palma de Mallorca).
  10. 57. Willermain, F., Bruyns, C., Hamdane, M., Willems, F., Baudson, N., Velu, T., & Caspers, L. (1999). Ligation of CD-40 on human retinal pigment epithelial cells in vitro does not induce a complete antigen-pesenting cell phenotype. Paper session presented at ARVO (1999: USA).
  11. 58. Willermain, F., Bali, E., Velu, T., & Caspers, L. (1999). Role F CD40 Expression on HRPE cells. Paper session presented at EVER (10/99: Palma de Mallorca Spain).
  12. 59. Bali, E., Willermain, F., Caspers, L., Velu, T., Libert, J., & Bruyns, C. (1999). Viral but not cellular interleukin-10 gene transfer reduces the severity of experimental PVR. Paper session presented at ARVO (1999: USA).

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 Suivant >>